News stories about Stericycle (NASDAQ:SRCL) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Stericycle earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave news headlines about the business services provider an impact score of 48.2888657049323 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Here are some of the news headlines that may have effected Accern Sentiment Analysis’s rankings:

Shares of Stericycle stock opened at $63.78 on Thursday. Stericycle has a 52-week low of $63.36 and a 52-week high of $63.99. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 0.88. The stock has a market cap of $5.49 billion, a PE ratio of 14.70, a PEG ratio of 1.44 and a beta of 0.39.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Thursday, May 3rd. The business services provider reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.16. Stericycle had a net margin of 0.19% and a return on equity of 14.14%. The business had revenue of $895.00 million for the quarter, compared to analyst estimates of $880.48 million. During the same period in the previous year, the business posted $1.09 earnings per share. The business’s revenue was up .3% compared to the same quarter last year. equities analysts anticipate that Stericycle will post 4.61 earnings per share for the current fiscal year.

A number of research firms have commented on SRCL. ValuEngine lowered shares of Stericycle from a “sell” rating to a “strong sell” rating in a research note on Wednesday, May 2nd. BMO Capital Markets lifted their price objective on shares of Stericycle from $64.00 to $67.00 and gave the company a “market perform” rating in a research note on Friday, May 4th. Royal Bank of Canada lifted their price objective on shares of Stericycle to $75.00 and gave the company an “underperform” rating in a research note on Friday, January 19th. Barrington Research set a $75.00 price objective on shares of Stericycle and gave the company a “buy” rating in a research note on Monday. Finally, BidaskClub upgraded shares of Stericycle from a “hold” rating to a “buy” rating in a research note on Wednesday, March 21st. Two research analysts have rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $78.63.

In other news, Director Jack W. Schuler purchased 10,000 shares of the company’s stock in a transaction dated Thursday, March 1st. The shares were acquired at an average cost of $62.59 per share, for a total transaction of $625,900.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 3.50% of the company’s stock.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.

Insider Buying and Selling by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with's FREE daily email newsletter.